SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $202,000 | +47.4% | 1,829 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $137,000 | -17.5% | 1,829 | -13.9% | 0.00% | 0.0% |
| Q1 2022 | $166,000 | -23.5% | 2,124 | -11.1% | 0.00% | 0.0% |
| Q4 2021 | $217,000 | -25.9% | 2,389 | -24.5% | 0.00% | -50.0% |
| Q3 2021 | $293,000 | +7.3% | 3,166 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $273,000 | -75.1% | 3,512 | -76.1% | 0.00% | -71.4% |
| Q1 2021 | $1,096,000 | -55.0% | 14,712 | +2.8% | 0.01% | -58.8% |
| Q4 2020 | $2,436,000 | +5.9% | 14,305 | -12.7% | 0.02% | 0.0% |
| Q3 2020 | $2,300,000 | -19.4% | 16,377 | -8.0% | 0.02% | -26.1% |
| Q2 2020 | $2,855,000 | +33.9% | 17,800 | -18.3% | 0.02% | +109.1% |
| Q1 2020 | $2,132,000 | +46.2% | 21,800 | +92.9% | 0.01% | 0.0% |
| Q4 2019 | $1,458,000 | +321.4% | 11,300 | +145.7% | 0.01% | +266.7% |
| Q3 2019 | $346,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |